Abstract:Escherichia coli was genetically engineered to produce recombinant tumor necrosis factor-related apoptosis inducing ligand (Apo2L/TRAIL) using a temperature-inducible expression system. To create a fed-batch culture condition that allows efficient production of TRAIL, different feeding strategy including discontinuous, DO-stat and pH-stat feeding strategies were compared. Then, a special 2-stage feeding strategy was developed. High concentration of biomass (300g wet cell weight per liter of culture broth) and active soluble TRAIL protein (1.1g/L) was obtained by applying a high-cell-density cultivation procedure with the 2-stage feeding strategy. Cultivation of recombinant E. coli was started as a batch process at 30 degrees C and then followed by fed-batch culture when the dissolved oxygen concentration presented a steep increase resulted from the exhaustion of glucose in the medium. At the first phase of fermentation (batch phase), agitation rate was enhanced to control dissolved oxygen at 30 percent. When glucose in the medium was used up, indicated by a sudden rise in pH value and dissolved oxygen, the second phase (fed-batch phase) was started with glucose and nitrogen resource being supplied automatically. At the beginning of fed-batch operation, stirrer rate was cascaded with dissolved oxygen signals to keep it at 20 percent (DO-stat). During the fed-batch phase, glucose was limited to control the specific growth rate under the critical value microcrit, to avoid acetic acid excretion. When the stirrer speed arrived at its up-limit, the flow rate of feed was kept constant. In the inducing phase(42 degrees C for 4h) glucose was fed as a pH regulating agent (pH-stat) and the specific growth rate and dissolved oxygen decreased sharply. Aqueous ammonia was used for maintaining pH value at 7.0 throughout the first two phases. In the whole fermentation, acetic acid concentration didn't exceed 2.9 g/L. At the end of the high-cell-density cultivation process, no acetic acid could be detected in the medium. These results indicated that our fed-batch strategy was able to prevent acetate accumulation significantly. Although high cell density has been achieved, the induction process was not optimized satisfactorily and much work should be done further. Furthermore, since no special ways, like pure oxygen, pressure, has been used in our experiments, this efficient approaches would be useful not only in a pilot scale but also in an industry scale. Finally, simple purification procedure based on immobilized metal affinity column (IMAC) and CM-Sepharose column was implemented to isolate the TRAIL. Yields of more than 800mg TRAIL per liter of culture broth were obtained, the final purity reaching more than 95%. The purified TRAIL showed strong cytotoxity activity against human pancreatic 1990 tumor cells, with ED50 about 1.6 microg/mL.

Production of Recombinant Tumor Targeting Peptide LTL-TNF by High Cell Density Culture of Escherichia Coli and DO-stat Fed-Batch Condition

Fed-batch Production of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Soluble Form in Escherichia Coli and Its Purification and Characterization.

Statistical Medium Optimization and DO-STAT Fed-Batch Fermentation for Enhanced Production of Tyrosine Phenol Lyase in Recombinant Escherichia Coli.

High-level production of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in high-density cultivation of recombinant Escherichia coli using a combined feeding strategy

Enhanced Production of L-Tryptophan with Glucose Feeding and Surfactant Addition and Related Metabolic Flux Redistribution in the Recombinant Escherichia Coli

[High-Cell Density Cultivation of Recombinant Escherichia Coli for Production of TRAIL by Using a 2-Stage Feeding Strategy].

Expression of tumor necrosis factor receptor-immunoglobulin G1 Fc fusion protein in glycoengineered Pichia pastoris

Development of A Fed-Batch Process for the Production of Anticancer Drug Tat(M)-Survivin(T34a) in Escherichia Coli

Optimization of Engineering Strain BL21 (DE3) Expressing Tumor Necrosis Factor Receptors 1 PLAD

[Optimization of fermentation of recombinant human Endostatin (rh-Endostatin) expression in Escherichia coli]

Optimization of High Cell Culture of Recombinant E.coli HT02 for High Expression of HT-1 Fusion Protein

High Efficient Expression and Purification of the Escherichia Coli T-protein

Enhancement of heterologous protein production in Corynebacterium glutamicum via atmospheric and room temperature plasma mutagenesis and high-throughput screening

Optimization of Culture on the Overproduction of TRAIL in High-Cell-density Culture by Recombinant Escherichia Coli.

High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization

Study on fermentation of recombinant bacterial strain of human mutant tumor necrosis factor-α

Optimization of Fed-batch Culture of Recombinant E.coli. for High Expression of Glucagon Like Peptide-1

Improved production of the tallysomycin H-1 in Streptoalloteichus hindustanus SB8005 strain by fermentation optimization

Human growth hormone production by high cell density fermentation of recombinant Escherichia coli

Ribosome engineering and fermentation optimization leads to overproduction of tiancimycin A, a new enediyne natural product from Streptomyces sp. CB03234

Development of Production Procedure and Quality Control Method for Recombinant CHO Cells with Human Type Ⅱ Tumor Necrosis Factor Receptor-Fc Fusion Gene